Advanced in Migraine with Brainstem Aura

Markus Farkkila

Helsinki, FI 
Advanced in Migraine with Brainstem Aura
Helsinki, FI 
OverviewLocationsClinical Research

Overview

Markus Farkkila practices in Helsinki, Finland. Mr. Farkkila is rated as an Advanced expert by MediFind in the treatment of Migraine with Brainstem Aura. His top areas of expertise are Migraine with Brainstem Aura, Familial Hemiplegic Migraine, Migraine, and Sporadic Hemiplegic Migraine.

His clinical research consists of co-authoring 20 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 3 articles in the study of Migraine with Brainstem Aura.

Gender
Male

Locations

Helsinki, Finland

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

The Efficacy of L-cysteine in Prevention of Cluster Headache. Randomized Intervention Trial With a Medical Device (Acetium® Capsules)
The Efficacy of L-cysteine in Prevention of Cluster Headache. Randomized Intervention Trial With a Medical Device (Acetium® Capsules)
Enrollment Status: Completed
Publish Date: February 17, 2021
Intervention Type: Drug
Study Phase: Not Applicable
The Efficacy of L-cysteine in Prevention of Headache Attacks in Migraine Patients. Randomized Intervention Trial With a Medical Device (Acetium®Capsules)
The Efficacy of L-cysteine in Prevention of Headache Attacks in Migraine Patients. Randomized Intervention Trial With a Medical Device (Acetium®Capsules)
Enrollment Status: Completed
Publish Date: February 17, 2021
Intervention Type: Drug
Study Phase: Not Applicable
View 1 Less Clinical Trial

20 Total Publications

Genome-wide analysis of 102,084 migraine cases identifies 123 risk loci and subtype-specific risk alleles.
Genome-wide analysis of 102,084 migraine cases identifies 123 risk loci and subtype-specific risk alleles.
Journal: Nature genetics
Published: January 12, 2021

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Farkkila's expertise for a condition
ConditionClose
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile